Conference
Physicians' and Patients' Perspectives on Treatments in ITP - a Multi-Country Perspective: Results from the ITP World Impact Survey (I-WISh)
Abstract
Treatment strategies for immune thrombocytopenia (ITP) aim to achieve a platelet count associated with adequate hemostasis while maximizing patient (pt) quality of life (QoL) and minimizing treatment-emergent toxicities. However, physicians' (MDs) and pts' treatment goals have not been studied and compared.
I-WISh is a cross-sectional survey of 1507 ITP pts and 472 MDs across 13 countries studying burden of ITP and pt QoL …
Authors
Bussel JB; Ghanima W; Tomiyama Y; Arnold DM; Provan D; Hou M; Santoro C; Laborde S; Kruse A; Kruse C
Volume
134
Publisher
American Society of Hematology
Publication Date
November 13, 2019
DOI
10.1182/blood-2019-130591
Conference proceedings
Blood
Issue
Supplement_1
ISSN
0006-4971